FDA related issues; DTC advertizing follow on biologics-(biosimilars); Health care reform issues as they relate to pharmaceutical industry in general and sanofi-aventis in particular
Manufacturing pricing or rebate obligations for heath benefits related to pharmaceuticals; Medicare, Medicaid and veterans administration and public health service programs
Worked with pheochomocytoma group on continueing funding for disease research
prepared materials for assessment of likelihood of legislative action on S.515 Patent Reform Act of 2009
Monitoring Medicaid and Medicare issues in Health Car Reform Bills
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate
Related Foreign Entities:
sanofi-aventis (Paris, FRA); contribution to lobbying: $0; ownership 100%
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Chief Health Counsel, Senator Thomas Coburn
House Cmmtee on Ways and Meas, Dpty Staff Dr
Health Policy Director, Senate Labor and Human R
Executive Dr, Adv Council on Social Security
Special Asst to Chief of Staff, DHHS
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Q2 Report
Registration
Q1 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...